Estée Lauder 10-Q 2025-03-31
Filed 2025-05-01. 7 sections, 349K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________________________________
FORM 10-Q
(Mark One)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2025
or
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 1-14064
The Estée Lauder Companies Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 11-2408943 | ||||||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||||||||
| 767 Fifth Avenue, New York, New York | 10153 | ||||||||||||||||
| (Address of principal executive offices) | (Zip Code) |
212-572-4200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Class A Common Stock, $.01 par value | EL | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☒ | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
At April 24, 2025, 234,209,951 shares of the registrant’s Class A Common Stock, $.01 par value, and 125,542,029 shares of the registrant’s Class B Common Stock, $.01 par value, were outstanding.
THE ESTÉE LAUDER COMPANIES INC.
INDEX
| Page | |||||
| Part I. Financial Information | |||||
| Item 1. Financial Statements (Unaudited) | |||||
| Consolidated Statements of Earnings (Loss) — Three and Nine Months Ended March 31, 2025 and 2024 | 2 | ||||
| Consolidated Statements of Comprehensive Income (Loss) — Three and Nine Months Ended March 31, 2025 and 2024 | 3 | ||||
| Consolidated Balance Sheets — March 31, 2025 and June 30, 2024 | 4 | ||||
| Consolidated Statements of Cash Flows — Nine Months Ended March 31, 2025 and 2024 | 5 | ||||
| Notes to Consolidated Financial Statements | 6 | ||||
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 37 | ||||
| Item 3. Quantitative and Qualitative Disclosures About Market Risk | 71 | ||||
| Item 4. Controls and Procedures | 71 | ||||
| Part II. Other Information | |||||
| Item 1. Legal Proceedings | 71 | ||||
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 72 | ||||
| Item 5. Other Information | 72 | ||||
| Item 6. Exhibits | 72 | ||||
| Signatures | 73 |
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED STATEMENTS OF EARNINGS (LOSS)
(Unaudited)
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||||||||
| (In millions, except per share data) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||||||||||
| Net sales | $ | 3,550 | $ | 3,940 | $ | 10,915 | $ | 11,737 | ||||||||||||||||||||||||||||||
| Cost of sales | 889 | 1,107 | 2,774 | 3,331 | ||||||||||||||||||||||||||||||||||
| Gross profit | 2,661 | 2,833 | 8,141 | 8,406 | ||||||||||||||||||||||||||||||||||
| Operating expenses | ||||||||||||||||||||||||||||||||||||||
| Selling, general and administrative | 2,258 | 2,284 | 7,141 | 7,177 | ||||||||||||||||||||||||||||||||||
| Restructuring and other charges | 97 | 18 | 375 | 26 | ||||||||||||||||||||||||||||||||||
| Impairment of goodwill and other intangible assets | — | — | 861 | — | ||||||||||||||||||||||||||||||||||
| Talcum litigation settlement agreements | — | — | 159 | — | ||||||||||||||||||||||||||||||||||
| Total operating expenses | 2,355 | 2,302 | 8,536 | 7,203 | ||||||||||||||||||||||||||||||||||
| Operating income (loss) | 306 | 531 | (395) | 1,203 | ||||||||||||||||||||||||||||||||||
| Interest expense | 87 | 94 | 269 | 287 | ||||||||||||||||||||||||||||||||||
| Interest income and investment income, net | 27 | 45 | 85 | 126 | ||||||||||||||||||||||||||||||||||
| Other components of net periodic benefit cost | 5 | (4) | 10 | (9) | ||||||||||||||||||||||||||||||||||
| Earnings (loss) before income taxes | 241 | 486 | (589) | 1,051 | ||||||||||||||||||||||||||||||||||
| Provision (benefit) for income taxes | 82 | 151 | (2) | 356 | ||||||||||||||||||||||||||||||||||
| Net earnings (loss) | 159 | 335 | (587) | 695 | ||||||||||||||||||||||||||||||||||
| Net earnings attributable to redeemable noncontrolling interest | — | (5) | — | (21) | ||||||||||||||||||||||||||||||||||
| Net earnings (loss) attributable to The Estée Lauder Companies Inc. | $ | 159 | $ | 330 | $ | (587) | $ | 674 | ||||||||||||||||||||||||||||||
| Net earnings (loss) attributable to The Estée Lauder Companies Inc. per common share | ||||||||||||||||||||||||||||||||||||||
| Basic | $ | .44 | $ | .92 | $ | (1.63) | $ | 1.88 | ||||||||||||||||||||||||||||||
| Diluted | $ | .44 | $ | .91 | $ | (1.63) | $ | 1.87 | ||||||||||||||||||||||||||||||
| Weighted average common shares outstanding | ||||||||||||||||||||||||||||||||||||||
| Basic | 360.3 | 359.1 | 359.9 | 358.8 | ||||||||||||||||||||||||||||||||||
| Diluted | 361.4 | 360.8 | 359.9 | 360.4 |
See notes to consolidated financial statements.
THE ESTÉE LAUDER COMPANIES INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)
| Three Months Ended March 31, | Nine Months Ended March 31, | ||||||||||||||||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||||||||||||||
| Net earnings (loss) | $ | 159 | $ | 335 | $ | (587) | $ | 695 | |||||||||||||||||||||||||||||||||
| Other comprehensive income (loss): | |||||||||||||||||||||||||||||||||||||||||
| Net cash flow hedge gain (loss) | (24) | 21 | (26) | (7) | |||||||||||||||||||||||||||||||||||||
| Cro |
Showing the first 8K of 176K characters. Open the full section
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
RESULTS OF OPERATIONS
We manufacture, market and sell beauty products including those in the skin care, makeup, fragrance and hair care categories, which are distributed in approximately 150 countries and territories. The following table is a comparative summary of operating results for the three and nine months ended March 31, 2025 and 2024, and reflects the basis of presentation described in Notes to Consolidated Financial Statements, Note 1 – Summary of Significant Accounting Policies for all periods presented. Products and services that do not meet our definition of skin care, makeup, fragrance and hair care have been included in the “other” category.
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||||||||||||||||||
| (In millions) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||||||||||
| NET SALES | ||||||||||||||||||||||||||||||||||||||
| By Product Category: | ||||||||||||||||||||||||||||||||||||||
| Skin Care | $ | 1,807 | $ | 2,060 | $ | 5,257 | $ | 5,873 | ||||||||||||||||||||||||||||||
| Makeup | 1,035 | 1,136 | 3,223 | 3,365 | ||||||||||||||||||||||||||||||||||
| Fragrance | 557 | 575 | 1,931 | 1,948 | ||||||||||||||||||||||||||||||||||
| Hair Care | 126 | 143 | 424 | 464 | ||||||||||||||||||||||||||||||||||
| Other | 25 | 26 | 80 | 88 | ||||||||||||||||||||||||||||||||||
| 3,550 | 3,940 | 10,915 | 11,738 | |||||||||||||||||||||||||||||||||||
| Returns associated with restructuring and other activities | — | — | — | (1) | ||||||||||||||||||||||||||||||||||
| Net sales | $ | 3,550 | $ | 3,940 | $ | 10,915 | $ | 11,737 | ||||||||||||||||||||||||||||||
| By Region**(1)****:** | ||||||||||||||||||||||||||||||||||||||
| The Americas | $ | 1,052 | $ | 1,117 | $ | 3,462 | $ | 3,567 | ||||||||||||||||||||||||||||||
| Europe, the Middle East & Africa | 1,358 | 1,647 | 4,082 | 4,488 | ||||||||||||||||||||||||||||||||||
| Asia/Pacific | 1,140 | 1,176 | 3,371 | 3,683 | ||||||||||||||||||||||||||||||||||
| 3,550 | 3,940 | 10,915 | 11,738 | |||||||||||||||||||||||||||||||||||
| Returns associated with restructuring and other activities | — | — | — | (1) | ||||||||||||||||||||||||||||||||||
| Net sales | $ | 3,550 | $ | 3,940 | $ | 10,915 | $ | 11,737 | ||||||||||||||||||||||||||||||
| OPERATING INCOME (LOSS) | ||||||||||||||||||||||||||||||||||||||
| By Product Category: | ||||||||||||||||||||||||||||||||||||||
| Skin Care | $ | 361 | $ | 468 | $ | 784 | $ | 920 | ||||||||||||||||||||||||||||||
| Makeup | 14 | 66 | (382) | 56 | ||||||||||||||||||||||||||||||||||
| Fragrance | 32 | 29 | (354) | 267 | ||||||||||||||||||||||||||||||||||
| Hair Care | (13) | (25) | (34) | (50) | ||||||||||||||||||||||||||||||||||
| Other | 9 | 11 | (25) | 38 | ||||||||||||||||||||||||||||||||||
| 403 | 549 | (11) | 1,231 | |||||||||||||||||||||||||||||||||||
| Charges associated with restructuring and other activities | (97) | (18) | (384) | (28) | ||||||||||||||||||||||||||||||||||
| Operating income (loss) | $ | 306 | $ | 531 | $ | (395) | $ | 1,203 | ||||||||||||||||||||||||||||||
| By Region**(1)****:** | ||||||||||||||||||||||||||||||||||||||
| The Americas | $ | 8 | $ | (6) | $ | (983) | $ | (243) | ||||||||||||||||||||||||||||||
| Europe, the Middle East & Africa | 239 | 302 | 645 | 825 | ||||||||||||||||||||||||||||||||||
| Asia/Pacific | 156 | 253 | 327 | 649 | ||||||||||||||||||||||||||||||||||
| 403 | 549 | (11) | 1,231 | |||||||||||||||||||||||||||||||||||
| Charges associated with restructuring and other activities | (97) | (18) | (384) | (28) | ||||||||||||||||||||||||||||||||||
| Operating income (loss) | $ | 306 | $ | 531 | $ | (395) | $ | 1,203 | ||||||||||||||||||||||||||||||
(1) The net sales from the Company's travel retail business are included in the Europe, the Middle East & Africa region, and operating income attributable to these net sales are included in that region and in The Americas. The exception is for net sales and operating income of Dr.Jart+ in the travel retail channel in Korea that are reflected in Korea in the Asia/Pacific region. During the fiscal 2025 second quarter, the Company exited Dr.Jart+ from the travel retail channel in Korea.
THE ESTÉE LAUDER COMPANIES INC.
The following table presents certain consolidated earnings (loss) data as a percentage of net sales:
| **Three Months E |
Showing the first 8K of 159K characters. Open the full section
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
The information required by this item is set forth in Item 2 of this Quarterly Report on Form 10-Q under the caption Liquidity and Capital Resources - Market Risk and is incorporated herein by reference.
Item 4. Controls and Procedures.
Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and to ensure that information required to be disclosed is accumulated and communicated to management, including our principal executive and financial officers, to allow timely decisions regarding disclosure. The Chief Executive Officer and the Chief Financial Officer, with assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of March 31, 2025 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.
As part of our review of internal control over financial reporting, we make changes to systems and processes to improve such controls and increase efficiencies, while ensuring that we maintain an effective internal control environment. There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the third quarter of fiscal 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
For a discussion of legal proceedings, see Notes to Consolidated Financial Statements, Note 8 – Commitments and Contingencies.
THE ESTÉE LAUDER COMPANIES INC.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Share Repurchase Program
We are authorized by the Board of Directors to repurchase shares of our Class A Common Stock in the open market or in privately negotiated transactions, depending on market conditions and other factors. The following table provides information relating to our repurchase of Class A Common Stock during the referenced periods:
| Period | Total Number of Shares Purchased**(1)** | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Program | Maximum Number of Shares that May Yet Be Purchased Under the Program**(2)** | ||||||||||||||||||||||
| January 2025 | 8,769 | $ | 84.30 | — | 25,073,242 | |||||||||||||||||||||
| February 2025 | 1,915 | 73.40 | — | 25,073,242 | ||||||||||||||||||||||
| March 2025 | — | — | — | 25,073,242 | ||||||||||||||||||||||
| 10,684 | 82.35 | — | ||||||||||||||||||||||||
(1)Reflects shares that were repurchased by the Company to satisfy tax withholding obligations upon the payout of certain stock-based compensation arrangements.
(2)The Board of Directors has authorized the current repurchase program for up to 256.0 million shares. The total amount was last increased by the Board on October 31, 2018. Our repurchase program does not have an expiration date.
Beginning in December 2022, we suspended the repurchase of shares of our Class A Common Stock under our publicly announced program. We may resume repurchases in the future.
Item 5. Other Information.
Trading Arrangements
During the fiscal 2025 third quarter, none of the Company’s directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408(a) of Regulation S-K under the Exchange Act.
Item 6. Exhibits.
| Exhibit Number | Description | |||||||
| 31.1 | Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (CEO). | |||||||
| 31.2 | Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (CFO). | |||||||
| 32.1 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (CEO). (furnished) | |||||||
| 32.2 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (CFO). (furnished) | |||||||
| 101.1 | The following materials from The Estée Lauder Companies Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Earnings (Loss), (ii) the Consolidated Statements of Comprehensive Income (Loss), (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) Notes to Consolidated Financial Statements | |||||||
| 104 | The cover page from The Estée Lauder Companies Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 is formatted in iXBRL | |||||||
† Exhibit is a management contract or compensatory plan or arrangement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| THE ESTÉE LAUDER COMPANIES INC. | ||||||||
| By: | /s/ AKHIL SHRIVASTAVA | |||||||
| Date: May 1, 2025 | Akhil Shrivastava | |||||||
| Executive Vice President and Chief Financial Officer | ||||||||
| (Principal Financial and Accounting Officer) |